Serotonin and pain: evidence that activation of 5-HT1A receptors does not elicit antinociception against noxious thermal, mechanical and chemical stimuli in mice
- 1 July 1994
- journal article
- Published by Wolters Kluwer Health in Pain
- Vol. 58 (1), 45-61
- https://doi.org/10.1016/0304-3959(94)90184-8
Abstract
In this study, we examined whether activation of 5-HT1A receptors elicits antinociception in response to acute noxious chemical, thermal and mechanical stimuli in mice. In the writhing test, both agonists (e.g., 8-OH-DPAT, S 14671 and WY 50,324) and partial agonists (e.g., buspirone and gepirone) elicited a pronounced antinociception. However, antagonists (e.g., (-)-alprenolol and WAY 100,135) also induced antinociception and, at lower (inactive) doses, failed to modify the action of agonists. In addition, the separation between doses required for induction of antinociception as compared to those required for induction of ataxia (in the rotarod test) was variable and low for both agonists (median: 1.9) and partial agonists (median: 1.3), although it was somewhat greater for antagonists (> or = 3.3). In the hot-plate test, only certain agonists (e.g., 8-OH-DPAT) and partial agonists (e.g., gepirone) elicited antinociception and their actions were not attenuated by 5-HT1A antagonists which, themselves, were inactive in this paradigm. The 5-HT1C/2 antagonist, ritanserin, the 5-HT3 antagonist, ondansetron, the dopamine D2 receptor antagonist, raclopride, and the alpha 1-adrenoceptor antagonist, prazosin, were also ineffective in modifying the antinociception evoked by 5-HT1A agonists and partial agonists in the hot-plate test. In contrast, their actions were strongly attenuated by the alpha 2-adrenoceptor antagonist, idazoxan. In the tail-flick tests to noxious heat and noxious pressure, 5-HT1A receptor agonists, partial agonists and antagonists generally failed to induce antinociception. Moreover, modulation of stimulus intensity (from very weak to very intense) did not reveal any influence upon the latency to respond. In conclusion, in the writhing test, the data provide no evidence for a specific antinociceptive effect of the activation of 5-HT1A receptors. Further, in the hot-plate test, for those 5-HT1A agonists and partial agonists which induce antinociception, alpha 2-adrenoceptors rather than 5-HT1A receptors are implicated in their actions. Finally, in reflexive tests, irrespective of stimulus quality or intensity, 5-HT1A agonists and partial agonists do not mediate antinociception. These data suggest that the activation of 5-HT1A receptors does not, under these conditions of acute noxious stimulation, elicit antinociception.Keywords
This publication has 60 references indexed in Scilit:
- OPPOSITE MODULATION OF 5-HT1A RECEPTOR-MEDIATED SPONTANEOUS TAIL- FLICKS BY, AND, RECEPTORSBehavioural Pharmacology, 1992
- Spinal 5-HT3 receptor-mediated antinociception: possible release of GABAJournal of Neuroscience, 1991
- Anticonflict and discriminative stimulus effects of the 5‐HT1A compounds WY‐47,846 and WY‐48,723 and the mixed 5‐HT1A agonist/5‐HT2 antagonist WY‐50,324 in pigeonsDrug Development Research, 1991
- Heterogeneity of α2‐adrenoceptors in rat cortex but not human platelets can be defined by 8‐OH‐DPAT, RU 24969 and methysergideBritish Journal of Pharmacology, 1990
- Novel antihypertensive drug reveals unexpected complexities in β-adrenoceptor pharmacologyTrends in Pharmacological Sciences, 1989
- Effect of 5-hydroxytryptamine precursors on morphine analgesia in the formalin testPharmacology Biochemistry and Behavior, 1988
- The α2-adrenoceptor antagonist activity of ipsapirone and gepirone is mediated by their common metabolite 1-(2-pyrimidinyl)-piperazine (PmP)European Journal of Pharmacology, 1988
- Multiple and complex effects of buspirone on central dopaminergic systemPharmacology Biochemistry and Behavior, 1988
- Peripheral and spinal mechanisms of nociception.Physiological Reviews, 1987
- 5-Methoxy-N,N-dimethyltryptamine-induced analgesia is blocked by α-adrenoceptor antagonists in ratsBritish Journal of Pharmacology, 1986